This work has been retracted.
The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
Year: 2010
Type: article
Source: Blood
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: SPORE in Lymphoma, Checkpoint Abrogation and MEK 1/2 Inhibition in Myeloma, Signaling Pathways Regulating Epithelial Cell Survival, NF-kappaB Inhibitors and Differentiation-Inducers in Leukemia, Promotion of Nucleoside Analog Induced Apoptosis by HDIs, OSU-03012 therapy for glioblastoma, Lapatinib and Obatoclax combination therapy
OpenAlex ID: W2047542386
